Reducing Anticholinergic Burden in Hospitalised Older Adults: Analysis From the INFAR Study
Basic & Clinical Pharmacology & Toxicology · 2026
DOI: 10.1111/bcpt.70160 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, 2026. Written by Romana Santos Gama and 4 co-authors. Institution: Postgraduate Program in Pharmaceutical Services and Policies, Federal University of Bahia, Salvador, Bahia, Brazil. Major MEDLINE topics: Cholinergic Antagonists, Inappropriate Prescribing, Pharmacists, Cardiovascular Diseases. Cited 1 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Topics: Gerontologische Pflege
Abstract (original language)
This study aimed to evaluate the effectiveness of pharmacist‐led medication reviews in reducing the anticholinergic burden of hospitalised patients with cardiovascular diseases (CVDs), to identify which anticholinergic medications were most frequently prescribed or discontinued during hospitalisation and to investigate factors associated with an elevated anticholinergic burden via secondary analysis of the INFAR study. An uncontrolled before‐and‐after design was used, and medication reviews were performed for all patients so that the anticholinergic burden of medications prescribed to older adults during their hospital stay could be examined. The mean age of the 319 patients was 68.9 years (±6.2), and upon hospital admission, 40.4% were classified as having a high anticholinergic burden, decreasing to 22.6% at discharge. Multivariate analysis at admission indicated that polypharmacy (PR = 2.00; 95% CI = 1.47–2.72) and potentially inappropriate medication (PR = 4.47; 95% CI = 2.10–9.53) were independently associated with a higher anticholinergic burden; however, only inappropriate medication was significantly associated with a high burden (PR = 2.39; 95% CI = 1.54–3.71) at discharge. The results indicate that a clinical pharmacist‐led medication review may reduce the anticholinergic burden in older adults with CVD, highlighting the importance of such a review in promoting safer prescribing practices during hospitalisation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Postgraduate Program in Pharmaceutical Services and Policies, Federal University of Bahia, Salvador, Bahia, Brazil.
- Department of Internal Medicine, Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Bahia, Brazil.
- Department of Health Sciences, State University of Southwest Bahia, Vitória da Conquista Campus, Vitória da Conquista, Bahia, Brazil.
- Sarah Kubitschek Rehabilitation Centre, Brasília, Brazil.
- Multidisciplinary Institute in Health-Anísio Teixeira Campus, Federal University of Bahia, Vitória da Conquista, Bahia, Brazil.
ORCID profiles: Romana Santos Gama, Luiz Carlos Passos, Welma Wildes Amorim, Renato Morais Souza, Marcio Galvão Oliveira
Funding
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Cite
APA
Gama, R. S., Passos, L. C., Amorim, W. W., Souza, R. M., & Oliveira, M. G. (2026). Reducing Anticholinergic Burden in Hospitalised Older Adults: Analysis From the INFAR Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70160
Vancouver
Gama RS, Passos LC, Amorim WW, Souza RM, Oliveira MG. Reducing Anticholinergic Burden in Hospitalised Older Adults: Analysis From the INFAR Study. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70160
BibTeX
@article{Gama2026,
author = {Gama, Romana Santos and Passos, Luiz Carlos and Amorim, Welma Wildes and Souza, Renato Morais and Oliveira, Marcio Galvão},
title = {Reducing Anticholinergic Burden in Hospitalised Older Adults: Analysis From the INFAR Study},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
doi = {10.1111/bcpt.70160}
}
EUVIMED